This study aimed to explore the influence of GSTM1 and GSTT1 polymorphisms on MTX efficacy, assuming that the deletion polymorphisms leading to reduced enzymatic activity would cause MTX accumulation and subsequently enhance its effectiveness in patients with JIA. The gene discussed is GSTM1; the disease is juvenile idiopathic arthritis.